KPTI vs GILD: Which Stock is Better?
Side-by-side comparison of Karyopharm Therapeutics Inc and Gilead Sciences Inc in 2026
KPTI
Karyopharm Therapeutics Inc
$8.45
GILD
Gilead Sciences Inc
$140.45
Key Metrics Comparison
| Metric | KPTI | GILD | Winner |
|---|---|---|---|
| Market Cap | $186.66M | $172.56B | GILD |
| P/E Ratio | N/A | 20.51 | GILD |
| EPS (TTM) | $N/A | $6.78 | GILD |
| Revenue Growth | 0.1% | 0.0% | KPTI |
| Gross Margin | 9.9% | 78.8% | GILD |
Analyze KPTI
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KPTI or GILD a better investment?
Comparing KPTI and GILD: Karyopharm Therapeutics Inc has a market cap of $186.66M while Gilead Sciences Inc has $172.56B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KPTI and GILD?
KPTI (Karyopharm Therapeutics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KPTI or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KPTI or GILD?
KPTI has higher revenue growth at 0.1% vs 0.0% for GILD.
Which company is more profitable: KPTI or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 9.9% for KPTI.
Which is the larger company: KPTI or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $172.56B compared to $186.66M for KPTI.
Should I buy KPTI or GILD in 2026?
Both KPTI and GILD have investment merit. KPTI trades at $8.45 while GILD trades at $140.45. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KPTI and GILD stock?
Key differences: Market Cap ($186.66M vs $172.56B), P/E Ratio (N/A vs 20.5x), Revenue Growth (0.1% vs 0.0%), Gross Margin (9.9% vs 78.8%).